보고서 요약(국문)

개요
전 세계 근접방사선치료기기 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
근접방사선치료는 특정 유형의 암 및 기타 질환 치료에 사용되는 치료법입니다. 방사선원을 포함하는 씨앗, 리본 또는 캡슐을 종양 내부 또는 근처에 삽입하는 것을 의미합니다. 이는 때때로 내부 방사선 치료라고도 불립니다.
시장 동향: 성장 동인 및 제약 요인
암 발병률 증가
암 발병률 증가는 예측 기간 동안 전 세계 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, Breastcancer.org의 데이터에 따르면 2022년 3월 미국에서 여성에게서 약 287,850건의 침습성 유방암 신규 사례가 진단될 것으로 예상되었으며, 비침습성(상피내) 유방암 신규 사례는 51,400건이 발생할 것으로 예상되었습니다. 또한, 국제암연구기관(IARC)의 2020년 보고서에 따르면 2020년 전 세계적으로 약 230만 건의 유방암 신규 사례가 진단되었으며, 이는 다른 어떤 암보다 많은 수치입니다. 2040년에는 유방암 발병률이 약 300만 건에 이를 것으로 예상되며, 이러한 유방암 발생률 증가는 예측 기간 동안 근접방사선치료 시장의 성장을 촉진할 것으로 전망됩니다.
또한, 고령 인구 증가와 연구 활동 증가는 예측 기간 동안 세계 시장 성장을 견인하는 추가적인 요인입니다.

숙련된 전문가 부족
그러나 방사선 치료를 수행할 숙련된 전문가 부족은 예측 기간 동안 시장 성장을 저해할 것으로 예상됩니다. 또한, 인식 부족과 높은 비용은 예측 기간 동안 세계 시장 성장을 둔화시키는 추가적인 요인 중 하나입니다.
세분화 분석
세계 근접치료 기기 시장은 제품, 투여 유형, 적응증, 최종 사용자 및 지역별로 세분화됩니다.
시드 제품 유형 부문이 시장을 주도할 것으로 예상됩니다.
시드 제품 유형 부문의 시장 개발이 증가함에 따라 예측 기간 동안 세계 시장을 주도할 것으로 예상됩니다. 예를 들어, 2023년 2월, 의료 기술 기업이자 시드 근접치료 개발업체인 Isoray, Inc.는 비상장 기업인 Viewpoint Molecular Targeting, Inc.와 합병했습니다. 통합된 기업은 방사선, 방사성 의약품 및 영상 기술을 활용하여 암 치료법을 개선하고 암 환자의 종양 부위에 정확하고 표적화된 의료 용량을 직접 투여하는 데 집중할 것으로 예상됩니다. 또한, 2021년 1월, 이소레이 메디컬(Isoray Medical, Inc.)은 C4 이미징(C4 Imaging)의 시리우스(Sirius) 양성 신호 MRI(자기공명영상) 마커와 이소레이의 세슘-131 근접치료용 시드를 함께 사용하는 것에 대해 미국 식품의약국(FDA) 510(k) 승인을 획득했습니다. 더 나아가, 2020년 6월에는 전립선암, 뇌종양, 두경부암, 부인과 종양, 폐암 등에 사용되는 세슘-131 영구 근접치료용 시드를 FDA가 승인(510(k) 승인)하고 CE 마크를 획득했습니다.
지역 분석
북미 지역이 세계 시장을 주도할 것으로 예상됨
북미 지역의 암 발병률 증가와 시장 개발은 예측 기간 동안 북미 지역의 시장 성장을 촉진하고 세계 시장을 주도할 것으로 예상됩니다. 예를 들어, 미국 암 협회(American Cancer Society)에 따르면 2023년 1월 기준 유방암은 미국 여성에게 가장 흔한 암이었습니다. 유방암은 매년 전국에서 발생하는 여성 암의 30%(또는 3건 중 1건)를 차지합니다. 또한, 같은 자료에 따르면 2023년 말까지 여성에게서 침습성 유방암 신규 환자가 약 297,790명, 관상피내암(DCIS) 신규 환자가 약 55,720명 발생할 것으로 추정됩니다. 더불어, 통합 암 치료 분야의 세계적인 선도 기업인 제네시스케어(GenesisCare)는 2021년 7월, 플렉시트론(Flexitron) 근접방사선 치료 후장전기 시스템 27대를 주문하고 관련 지원 계약을 체결했습니다. 이 암 치료 장비는 제네시스케어가 최첨단 기술을 활용하면서 미국 내 모든 센터에서 환자들에게 고품질 치료를 제공하는 데 기여할 것입니다.

COVID-19 영향 분석
COVID-19 팬데믹은 세계 시장에 부정적인 영향을 미쳤습니다. 여러 국가에서 시행된 봉쇄 조치로 인해 방사선 치료 건수가 감소했고, 이는 시장 매출에 악영향을 미쳤습니다. 영국에서 인구 기반 연구를 통해 팬데믹 기간 동안 암이 방사선 치료에 미치는 영향을 분석했습니다. 이 연구는 2020년 4월, 5월, 6월의 주간 평균 방사선 치료 횟수가 2019년 같은 기간에 비해 크게 감소했음을 보여주었습니다. 그러나 봉쇄 조치가 완화됨에 따라 방사선 치료 시장은 향후 몇 년 동안 점진적으로 회복될 것으로 예상됩니다.
시장 세분화
제품별
• 시드
• 어플리케이터 및 애프터로더
• 근접치료 시스템
• 기타
투여 유형별
• 고선량률(HDR) 근접치료
• 저선량률(LDR) 근접치료
적응증별
• 전립선암
• 부인과암
• 유방암
• 두경부암
• 기타
최종 사용자별
• 병원
• 전문 클리닉
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
• 2021년 9월, 유니캔서(Unicancer)는 어큐레이(Accuray, Inc.)의 라딕액트(Radixact) 시스템과 클리어RT(ClearRT)를 인수했습니다. 유럽 환자들에게 맞춤형 치료를 제공하는 것을 목표로 합니다.
• 2021년 8월, iCAD, Inc.의 Xoft Axxent 전자 근접치료 시스템은 재발성 교모세포종 치료에서 이 치료를 받은 환자의 전반적인 생존율에 상당한 진전을 보였습니다.

• 2020년 6월, FDA 승인(510K 승인) 및 CE 마크를 획득한 세슘-131 영구 근접치료 시드는 전립선암, 뇌종양, 두경부암, 부인과 종양, 폐암 등에 사용됩니다.
경쟁 환경
시장의 주요 글로벌 업체로는 Varian Medical Systems, Inc., Becton, Dickinson & Company, Elekta AB, Isoray Medical, Inc., Eckert & Ziegler BEBIG, ICAD, Inc., CIVCO Medical Solutions, Theragenics Corporation, Carl Zeiss Meditec AG 및 Argon Medical이 있습니다.
보고서 구매 이유

• 제품, 투여 유형, 적응증, 최종 사용자 및 지역별 글로벌 근접치료기기 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 근접치료기기 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 근접치료기기 시장 보고서는 약 69개의 표, 69개의 그림, 182페이지 분량입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global brachytherapy devices market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Brachytherapy is a approach utilized for the treatment of specific kinds of cancer and additional conditions. It implicates positioning seeds, ribbons, or capsules that include a radiation source inside the body in or near the tumor. This is occasionally anointed as internal radiation therapy.
Market Dynamics: Drivers & Restraints
Increasing Cases of Cancer
The increasing cases of cancer are expected to boost the global market growth during the forecast period. For instance, according to data from Breastcancer.org, in March 2022, an estimated 287,850 new cases of invasive breast cancer were anticipated to be interpreted in females in the U.S., along with 51,400 fresh cases of non-invasive (in situ) breast cancer in 2022. Moreover, according to the International Agency for Research on Cancer (IARC) 2020 report, in 2020, about 2.3 million new cases of breast cancer were interpreted globally, over any other form of cancer, and by 2040, the incidence of breast cancer is projected to reach about 3 million cases and therefore, with the growing load of breast cancer expected to boost brachytherapy market over the forecast period.
Additionally, the growing geriatric population and increased research activities are among the additional factors boosting the global market during the forecast period.
Lack of Skilled Professionals
However, the shortage of skilled professionals to conduct radiotherapy is expected to hamper the market growth over the forecast period. Further, the lack of awareness and high cost are among the additional factors slowing the global market growth during the forecast period.
Segment Analysis
The global brachytherapy devices market is segmented based on product, dosage type, indication, end user and region.
Seeds Product Type Segment is Expected to Dominate Market
Owing to the increasing market developments in the seeds product type segment it is estimated to dominate the global market during the forecast period. For instance, in February 2023, Isoray, Inc., a medical technology corporation and developer in seed brachytherapy, merged with privately held Viewpoint Molecular Targeting, Inc. The integrated corporations’ focus is expected to be the refinement of cancer therapies utilizing radiation, radiopharmaceuticals, and imaging technologies so that accurate, targeted medical doses are administered straight to cancer patient tumor sites. Moreover, in January 2021, Isoray Medical, Inc., obtained U.S. Food and Drug Administration (FDA) 510(k) authorization for the usage of C4 Imaging’s Sirius positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds. Further, in June 2020, the FDA cleared (510 K authorized) and CE marked cesium-131 permanent brachytherapy seeds for Prostate cancer, Brain tumors, Head and neck, Gynecological tumors, Lung, etc.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the increased cancer cases and market developments in North America are expected to boost the regional market growth dominating the global market during the forecast period. For instance, according to the American Cancer Society in January 2023, breast cancer was the most common cancer in females in the United States. It accounts for 30% (or 1 in 3) of all recent female cancers in the nation annually. Also, according to the same reference, about 297,790 fresh cases of invasive breast cancer and 55,720 new cases of ductal carcinoma in situ (DCIS) are estimated to be diagnosed in females by the end of 2023. Further, in July 2021, GenesisCare, a top multinational provider of integrated cancer care, completed the order of 27 Flexitron brachytherapy afterloader systems, including assistance contracts. The cancer treatment devices intend to allow GenesisCare to persist to support in the latest world-class technology while delivering access to high-quality care to their patients throughout their U.S. centers.
COVID-19 Impact Analysis
The COVID-19 pandemic had a negative impact on the global market. The lockdown imposed in various countries led to reduced rates of radiotherapy, thereby affecting the revenue generated by the market. A population-based study was carried out in England to analyze the impact of cancer on radiotherapy during the pandemic. The study revealed a significant drop in mean weekly radiotherapy courses in April, May, and June 2020 compared to the corresponding months in 2019. However, with the easing of lockdown restrictions, the radiotherapy market is expected to recover gradually in the coming years.
Market Segmentation
By Product
• Seeds
• Applicators & Afterloaders
• Brachytherapy Systems
• Others
By Dosage Type
• High-Dose Rate (HDR) Brachytherapy
• Low-Dose Rate (LDR) Brachytherapy
By Indication
• Prostate Cancer
• Gynecological Cancer
• Breast Cancer
• Head and Neck Cancer
• Others
By End User
• Hospitals
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In September 2021, Unicancer acquired multiple Radixact Systems of Accuray, Inc. with the ClearRT with a purpose to deliver personalized therapy to patients in Europe.
• In August 2021, iCAD, Inc.’s Xoft Axxent Electronic Brachytherapy System for the treatment of recurrent glioblastoma demonstrated substantial progress in the general survival of patients who obtained this treatment.
• In Jun-2020, FDA authorized (510 K approved) and CE marked cesium-131 permanent brachytherapy seeds for Prostate cancer, Brain tumors, Head & Neck, Gynecological tumors, Lung etc.
Competitive Landscape
The major global players in the market include Varian Medical Systems, Inc., Becton, Dickinson & Company, Elekta AB, Isoray Medical, Inc., Eckert & Ziegler BEBIG, ICAD, Inc., CIVCO Medical Solutions, Theragenics Corporation, Carl Zeiss Meditec AG and Argon Medical.
Why Purchase the Report?
• To visualize the global brachytherapy devices market segmentation based on product, dosage type, indication, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of brachytherapy devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key product of all the major players.
The global brachytherapy devices market report would provide approximately 69 tables, 69 figures and 182 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Dosage Type
3.3. Snippet by Indication
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Cases of Cancer
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Lack of Skilled Professionals
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Technology Trend
5.6. Unmet Need
5.7. End-user Trend
5.8. SWOT Analysis
5.9. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Seeds*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Applicators & Afterloaders
7.4. Brachytherapy Systems
7.5. Others
8. By Dosage Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Type
8.1.2. Market Attractiveness Index, By Dosage Type
8.2. High-Dose Rate (HDR) Brachytherapy*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Low-Dose Rate (LDR) Brachytherapy
9. By Indication
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
9.1.2. Market Attractiveness Index, By Indication
9.2. Prostate Cancer*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Gynecological Cancer
9.4. Breast Cancer
9.5. Head and Neck Cancer
9.6. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Varian Medical Systems, Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Becton, Dickinson & Company
13.3. Elekta AB, Inc.
13.4. ISORAY MEDICAL, INC.
13.5. Eckert & Ziegler BEBIG
13.6. ICAD, Inc.
13.7. CIVCO Medical Solutions
13.8. Theragenics Corporation
13.9. Carl Zeiss Meditec AG
13.10. Argon Medical.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Varian Medical Systems, Inc., 4.	Key Developments, Becton, Dickinson & Company, Elekta AB, Inc., ISORAY MEDICAL, INC., Eckert & Ziegler BEBIG, ICAD, Inc., CIVCO Medical Solutions, Theragenics Corporation, Carl Zeiss Meditec AG, Argon Medical.

표 목록 (Tables)

List of Tables

Table 1 Global Brachytherapy Devices Market Value, By Dosage Type, 2024, 2029 & 2033 (US$ Million)

Table 2 Global Brachytherapy Devices Market Value, By Product Type, 2024, 2029 & 2033 (US$ Million)

Table 3 Global Brachytherapy Devices Market Value, By Technique Type, 2024, 2029 & 2033 (US$ Million)

Table 4 Global Brachytherapy Devices Market Value, By Application, 2024, 2029 & 2033 (US$ Million)

Table 5 Global Brachytherapy Devices Market Value, By End-User, 2024, 2029 & 2033 (US$ Million)

Table 6 Global Brachytherapy Devices Market Value, By Region, 2024, 2029 & 2033 (US$ Million)

Table 7 Global Brachytherapy Devices Market Value, By Dosage Type, 2024, 2029 & 2033 (US$ Million)

Table 8 Global Brachytherapy Devices Market Value, By Dosage Type, 2018-2033 (US$ Million)

Table 9 Global Brachytherapy Devices Market Value, By Product Type, 2024, 2029 & 2033 (US$ Million)

Table 10 Global Brachytherapy Devices Market Value, By Product Type, 2018-2033 (US$ Million)

Table 11 Global Brachytherapy Devices Market Value, By Technique Type, 2024, 2029 & 2033 (US$ Million)

Table 12 Global Brachytherapy Devices Market Value, By Technique Type, 2018-2033 (US$ Million)

Table 13 Global Brachytherapy Devices Market Value, By Application, 2024, 2029 & 2033 (US$ Million)

Table 14 Global Brachytherapy Devices Market Value, By Application, 2018-2033 (US$ Million)

Table 15 Global Brachytherapy Devices Market Value, By End-User, 2024, 2029 & 2033 (US$ Million)

Table 16 Global Brachytherapy Devices Market Value, By End-User, 2018-2033 (US$ Million)

Table 17 Global Brachytherapy Devices Market Value, By Region, 2024, 2029 & 2033 (US$ Million)

Table 18 Global Brachytherapy Devices Market Value, By Region, 2018-2033 (US$ Million)

Table 19 North America Brachytherapy Devices Market Value, By Dosage Type, 2018-2033 (US$ Million)

Table 20 North America Brachytherapy Devices Market Value, By Product Type, 2018-2033 (US$ Million)

Table 21 North America Brachytherapy Devices Market Value, By Technique Type, 2018-2033 (US$ Million)

Table 22 North America Brachytherapy Devices Market Value, By Application, 2018-2033 (US$ Million)

Table 23 North America Brachytherapy Devices Market Value, By End-User, 2018-2033 (US$ Million)

Table 24 North America Brachytherapy Devices Market Value, By Country, 2018-2033 (US$ Million)

Table 25 South America Brachytherapy Devices Market Value, By Dosage Type, 2018-2033 (US$ Million)

Table 26 South America Brachytherapy Devices Market Value, By Product Type, 2018-2033 (US$ Million)

Table 27 South America Brachytherapy Devices Market Value, By Technique Type, 2018-2033 (US$ Million)

Table 28 South America Brachytherapy Devices Market Value, By Application, 2018-2033 (US$ Million)

Table 29 South America Brachytherapy Devices Market Value, By End-User, 2018-2033 (US$ Million)

Table 30 South America Brachytherapy Devices Market Value, By Country, 2018-2033 (US$ Million)

Table 31 Europe Brachytherapy Devices Market Value, By Dosage Type, 2018-2033 (US$ Million)

Table 32 Europe Brachytherapy Devices Market Value, By Product Type, 2018-2033 (US$ Million)

Table 33 Europe Brachytherapy Devices Market Value, By Technique Type, 2018-2033 (US$ Million)

Table 34 Europe Brachytherapy Devices Market Value, By Application, 2018-2033 (US$ Million)

Table 35 Europe Brachytherapy Devices Market Value, By End-User, 2018-2033 (US$ Million)

Table 36 Europe Brachytherapy Devices Market Value, By Country, 2018-2033 (US$ Million)

Table 37 Asia-Pacific Brachytherapy Devices Market Value, By Dosage Type, 2018-2033 (US$ Million)

Table 38 Asia-Pacific Brachytherapy Devices Market Value, By Product Type, 2018-2033 (US$ Million)

Table 39 Asia-Pacific Brachytherapy Devices Market Value, By Technique Type, 2018-2033 (US$ Million)

Table 40 Asia-Pacific Brachytherapy Devices Market Value, By Application, 2018-2033 (US$ Million)

Table 41 Asia-Pacific Brachytherapy Devices Market Value, By End-User, 2018-2033 (US$ Million)

Table 42 Asia-Pacific Brachytherapy Devices Market Value, By Country, 2018-2033 (US$ Million)

Table 43 Middle East and Africa Brachytherapy Devices Market Value, By Dosage Type, 2018-2033 (US$ Million)

Table 44 Middle East and Africa Brachytherapy Devices Market Value, By Product Type, 2018-2033 (US$ Million)

Table 45 Middle East and Africa Brachytherapy Devices Market Value, By Technique Type, 2018-2033 (US$ Million)

Table 46 Middle East and Africa Brachytherapy Devices Market Value, By Application, 2018-2033 (US$ Million)

Table 47 Middle East and Africa Brachytherapy Devices Market Value, By End-User, 2018-2033 (US$ Million)

Table 48 Middle East and Africa Brachytherapy Devices Market Value, By Country, 2018-2033 (US$ Million)

Table 49 Elekta AB: Overview

Table 50 Elekta AB: Product Portfolio

Table 51 Elekta AB: Key Developments

Table 52 Varian Medical Systems, Inc.: Overview

Table 53 Varian Medical Systems, Inc.: Product Portfolio

Table 54 Varian Medical Systems, Inc.: Key Developments

Table 55 Eckert & Ziegler: Overview

Table 56 Eckert & Ziegler: Product Portfolio

Table 57 Eckert & Ziegler: Key Developments

Table 58 Theragenics Corporation: Overview

Table 59 Theragenics Corporation: Product Portfolio

Table 60 Theragenics Corporation: Key Developments

Table 61 Becton, Dickinson, and Company: Overview

Table 62 Becton, Dickinson, and Company: Product Portfolio

Table 63 Becton, Dickinson, and Company: Key Developments

Table 64 BEBIG Medical: Overview

Table 65 BEBIG Medical: Product Portfolio

Table 66 BEBIG Medical: Key Developments

Table 67 Sun Nuclear Corporation: Overview

Table 68 Sun Nuclear Corporation: Product Portfolio

Table 69 Sun Nuclear Corporation: Key Developments

Table 70 CIVCO Medical Solutions: Overview

Table 71 CIVCO Medical Solutions: Product Portfolio

Table 72 CIVCO Medical Solutions: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 2 Global Brachytherapy Devices Market Share, By Dosage Type, 2024 & 2033 (%)

Figure 3 Global Brachytherapy Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 4 Global Brachytherapy Devices Market Share, By Technique Type, 2024 & 2033 (%)

Figure 5 Global Brachytherapy Devices Market Share, By Application, 2024 & 2033 (%)

Figure 6 Global Brachytherapy Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 7 Global Brachytherapy Devices Market Share, By Region, 2024 & 2033 (%)

Figure 8 Global Brachytherapy Devices Market Y-o-Y Growth, By Dosage Type, 2024-2033 (%)

Figure 9 High-Dose Rate (HDR) Brachytherapy Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 10 Low-Dose Rate (LDR) Brachytherapy Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 11 Global Brachytherapy Devices Market Y-o-Y Growth, By Product Type, 2024-2033 (%)

Figure 12 Seeds Product Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 13 Brachytherapy Applicators Product Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 14 Brachytherapy Afterloaders Product Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 15 Electronic Brachytherapy Product Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 16 Global Brachytherapy Devices Market Y-o-Y Growth, By Technique Type, 2024-2033 (%)

Figure 17 Ultrasound-Guided Brachytherapy Technique Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 18 Magnetic Resonance Imaging (MRI)-Guided Brachytherapy Technique Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 19 Computed Tomography (CT)-Guided Brachytherapy Technique Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 20 Positron Emission Tomography (PET)-Guided Brachytherapy Technique Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 21 Others Technique Type in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 22 Global Brachytherapy Devices Market Y-o-Y Growth, By Application, 2024-2033 (%)

Figure 23 Prostate Cancer Application in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 24 Skin Cancer Application in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 25 Gynecological Cancer Application in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 26 Breast Cancer Application in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 27 Cervical Cancer Application in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 28 Others Application in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 29 Global Brachytherapy Devices Market Y-o-Y Growth, By End-User, 2024-2033 (%)

Figure 30 Hospitals End-User in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 31 Diagnostic Centers End-User in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 32 Radiotherapy Centers End-User in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 33 Ambulatory Surgical Centers End-User in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 34 Others End-User in Global Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 35 Global Brachytherapy Devices Market Y-o-Y Growth, By Region, 2024-2033 (%)

Figure 36 North America Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 37 North America Brachytherapy Devices Market Share, By Dosage Type, 2024 & 2033 (%)

Figure 38 North America Brachytherapy Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 39 North America Brachytherapy Devices Market Share, By Technique Type, 2024 & 2033 (%)

Figure 40 North America Brachytherapy Devices Market Share, By Application, 2024 & 2033 (%)

Figure 41 North America Brachytherapy Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 42 North America Brachytherapy Devices Market Share, By Country, 2024 & 2033 (%)

Figure 43 South America Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 44 South America Brachytherapy Devices Market Share, By Dosage Type, 2024 & 2033 (%)

Figure 45 South America Brachytherapy Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 46 South America Brachytherapy Devices Market Share, By Technique Type, 2024 & 2033 (%)

Figure 47 South America Brachytherapy Devices Market Share, By Application, 2024 & 2033 (%)

Figure 48 South America Brachytherapy Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 49 South America Brachytherapy Devices Market Share, By Country, 2024 & 2033 (%)

Figure 50 Europe Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 51 Europe Brachytherapy Devices Market Share, By Dosage Type, 2024 & 2033 (%)

Figure 52 Europe Brachytherapy Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 53 Europe Brachytherapy Devices Market Share, By Technique Type, 2024 & 2033 (%)

Figure 54 Europe Brachytherapy Devices Market Share, By Application, 2024 & 2033 (%)

Figure 55 Europe Brachytherapy Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 56 Europe Brachytherapy Devices Market Share, By Country, 2024 & 2033 (%)

Figure 57 Asia-Pacific Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 58 Asia-Pacific Brachytherapy Devices Market Share, By Dosage Type, 2024 & 2033 (%)

Figure 59 Asia-Pacific Brachytherapy Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 60 Asia-Pacific Brachytherapy Devices Market Share, By Technique Type, 2024 & 2033 (%)

Figure 61 Asia-Pacific Brachytherapy Devices Market Share, By Application, 2024 & 2033 (%)

Figure 62 Asia-Pacific Brachytherapy Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 63 Asia-Pacific Brachytherapy Devices Market Share, By Country, 2024 & 2033 (%)

Figure 64 Middle East and Africa Brachytherapy Devices Market Value, 2018-2033 (US$ Million)

Figure 65 Middle East and Africa Brachytherapy Devices Market Share, By Dosage Type, 2024 & 2033 (%)

Figure 66 Middle East and Africa Brachytherapy Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 67 Middle East and Africa Brachytherapy Devices Market Share, By Technique Type, 2024 & 2033 (%)

Figure 68 Middle East and Africa Brachytherapy Devices Market Share, By Application, 2024 & 2033 (%)

Figure 69 Middle East and Africa Brachytherapy Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 70 Elekta AB: Financials

Figure 71 Varian Medical Systems, Inc.: Financials

Figure 72 Eckert & Ziegler: Financials

Figure 73 Theragenics Corporation: Financials

Figure 74 Becton, Dickinson, and Company: Financials

Figure 75 BEBIG Medical: Financials

Figure 76 Sun Nuclear Corporation: Financials

Figure 77 CIVCO Medical Solutions: Financials

글로벌 근접방사선치료기기 시장 – 2023-2030

Global Brachytherapy Devices Market - 2023-2030